ArticleSignal transduction and targeted therapy2024

Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.

Xian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.